Download expert reporting on policy shifts, clinical trials, FDA decisions, and dealmaking in biopharma
Explore the critical developments shaping the biopharma industry in 2025. This editorial package delivers in-depth reporting on regulatory shifts, scientific milestones, investment activity, and global pressures that biotech and pharmaceutical leaders must understand to compete and grow in a rapidly evolving landscape.
- Clinical Trials to Watch: See which upcoming studies are drawing industry attention in 2025
- Global Competition: Examine how China and international dynamics are influencing biotech strategy
- FDA Decisions Ahead: Track approval decisions expected to impact development plans and pipelines
- JPMorgan Healthcare Insights: Discover what startup activity, deals, and investor signals reveal about market momentum
Download the full PDF to stay informed, spot emerging signals, and better navigate the state of biopharma in 2025.
Offered Free by: Industry Dive
See All Resources from: Industry Dive
